Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0013 | 0.0052 | 0.0052 |
Schistosoma mansoni | smad | 0.0013 | 0.0052 | 0.0122 |
Schistosoma mansoni | smad1 5 8 and | 0.0013 | 0.0052 | 0.0122 |
Echinococcus granulosus | Smad4 | 0.0013 | 0.0052 | 0.0122 |
Brugia malayi | hypothetical protein | 0.0021 | 0.0178 | 0.0134 |
Schistosoma mansoni | smad1 5 8 and | 0.0013 | 0.0052 | 0.0122 |
Leishmania major | hypothetical protein, conserved | 0.0021 | 0.0178 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0021 | 0.0178 | 0.5 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0185 | 0.274 | 0.9108 |
Brugia malayi | MH2 domain containing protein | 0.0185 | 0.274 | 0.2861 |
Echinococcus multilocularis | geminin | 0.0282 | 0.4247 | 0.4247 |
Echinococcus granulosus | smad | 0.0013 | 0.0052 | 0.0122 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0021 | 0.0178 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0021 | 0.0178 | 0.5 |
Echinococcus multilocularis | Cyclin dependent kinase 2 associated protein | 0.0188 | 0.2787 | 0.2787 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0178 | 0.0428 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0013 | 0.0052 | 0.0122 |
Echinococcus granulosus | Cyclin dependent kinase 2 associated protein | 0.0188 | 0.2787 | 0.6561 |
Schistosoma mansoni | hypothetical protein | 0.0282 | 0.4247 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0021 | 0.0178 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0188 | 0.2787 | 0.9268 |
Echinococcus granulosus | geminin | 0.0282 | 0.4247 | 1 |
Echinococcus multilocularis | smad | 0.0013 | 0.0052 | 0.0052 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0013 | 0.0052 | 0.0052 |
Brugia malayi | hypothetical protein | 0.0013 | 0.0064 | 0.0013 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0202 | 0.3003 | 0.707 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0021 | 0.0178 | 0.5 |
Schistosoma mansoni | deleted in oral cancer 1/cdk2-associated protein-like | 0.0188 | 0.2787 | 0.6561 |
Brugia malayi | Protein kinase domain containing protein | 0.0202 | 0.3003 | 0.3141 |
Schistosoma mansoni | smad1 5 8 and | 0.0013 | 0.0052 | 0.0122 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0021 | 0.0178 | 0.5 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0013 | 0.0052 | 0.0122 |
Brugia malayi | hypothetical protein | 0.0616 | 0.9447 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0282 | 0.4247 | 1 |
Echinococcus multilocularis | Smad4 | 0.0013 | 0.0052 | 0.0052 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0185 | 0.274 | 0.9108 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0013 | 0.0052 | 0.0122 |
Schistosoma mansoni | Smad4 | 0.0013 | 0.0052 | 0.0122 |
Onchocerca volvulus | Diphthamide biosynthesis protein 7 homolog | 0.0188 | 0.2787 | 0.5 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.0202 | 0.3003 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0021 | 0.0178 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.